This inventor holds 5 USPTO granted patents and 5 published patent applications and 4 EPO patents. Top assignee: Bayer Pharma Aktiengesellschaft. Active years: 2019-2026.
Company Filing History:
Years Active: 2019-2026
Title: Innovations of Andreas Sutter in Pharmaceutical Development
Introduction
Andreas Sutter is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on substituted indazoles. With a total of four patents to his name, Sutter's research focuses on the development of novel compounds that have the potential to treat various diseases.
Latest Patents
Sutter's latest patents revolve around substituted indazoles, which include methods for their production and pharmaceutical preparations containing these compounds. His work emphasizes the use of substituted indazoles for the treatment and prophylaxis of diseases such as endometriosis, rheumatoid arthritis, multiple sclerosis, and various other conditions. The applications of these compounds extend to the production of medicaments aimed at alleviating symptoms associated with these diseases.
Career Highlights
Andreas Sutter is currently employed at Bayer Pharma Aktiengesellschaft, where he continues to advance his research in pharmaceutical innovations. His expertise in the synthesis and application of substituted indazoles has positioned him as a key figure in the development of new therapeutic options.
Collaborations
Sutter collaborates with esteemed colleagues, including Ulrich Bothe and Holger Siebeneicher. Their combined efforts contribute to the advancement of pharmaceutical research and the development of effective treatments.
Conclusion
Andreas Sutter's work in the field of pharmaceuticals showcases his dedication to innovation and the development of new treatments for complex diseases. His contributions through patents and collaborations highlight the importance of research in improving healthcare outcomes.